Bull & Bear

Figures converted from TWD at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — Q1 2026 already refuted the bear's central margin-peak claim, but at $15.46 the price has done enough of the work that committing capital should wait for one more data point. The decisive tension is whether Q1's 26.5% gross margin survives Q2 2026, or whether the 100–200 bps of CCL pricing tailwind reverses on schedule. Bull carries the more recent evidence (Q1 print, April monthly revenue at an all-time high), but Bear's valuation math is unanswered: at today's price the stock sits above Bull's own modelled bull case of $15.68, so any margin disappointment compresses both EPS and the multiple at the same time. A Q2 2026 gross margin sustained at or above 25% with the Tripod/Gold Circuit revenue ratio not deteriorating further is the validator; a Q2 print below 24% closes the case for Bear.

Bull Case

Target $19.32 (~$10.1B market cap, +25% from $15.46), 12–18 months. Method: FY2026E EPS of $0.87 (Q1 actual $0.18 plus seasonally stronger Q2–Q4 at the April run-rate, i.e. 4× Q1 plus ~20% acceleration) × 22x forward P/E, which is below Compeq (47x trailing), Gold Circuit (67x trailing) and the Taiwan PCB peer-band midpoint, and above Tripod's pre-2024 self-history. Independently corroborates the $19.32 sell-side consensus mean target across 6 analysts (range $18.05–21.09). Disconfirming signal: Q2 2026 gross margin below 24% without a one-off explanation invalidates the durability claim and forces the long off.

Bear Case

Downside target $9.50 (~38% from $15.46), 12–18 months. Method: trailing EPS compresses from $0.63 to ~$0.48 (operating margin reverts ~310bp from 17.6% to ~14.5% as CCL pricing normalises, fixed-asset turnover rolls from 3.57x toward 3.0x on the FY2025–FY2026 capex step-up, and Chinese mainland competitors take 100–200bp of share at the mainstream multilayer tier) × 20x P/E, still a ~70% premium to Tripod's 10-year average of ~12x. Primary trigger: a quarterly gross margin print below 24% in Q2 or Q3 2026. Signal that forces a cover: Q2 2026 gross margin sustained at or above 26.5% combined with FCF/NI recovering above 0.8x and the Tripod/Gold Circuit revenue ratio stabilising at or above 1.10x.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries the more recent and more specific evidence: Q1 2026 gross margin 26.5% and April 2026 monthly revenue $260M together refute the bear's timing claim that Q3 2025 was the cycle peak, and they do so with the company's own next data points rather than projection. The single most important tension is whether the Q1 margin survives Q2 — every other thread (Gold Circuit share, capex cycle, FCF) becomes second-order if the gross margin re-rates higher rather than reverting. The opposing side could still be right because at $15.46 the share price already sits above Bull's modelled bull-case of $15.68, the dividend already exceeds FCF, and the Tripod/Gold Circuit revenue ratio is on a two-year compression trajectory that a single quarter cannot reverse — so a normalisation alone, without recession, gets to Bear's $9.50. The durable thesis breaker is the Tripod/Gold Circuit revenue ratio over the next 2–3 quarters (stabilising at or above 1.10x supports the long; crossing below 1.00x closes the case for Bear); the near-term evidence marker is the Q2 2026 gross margin print in August 2026. The verdict moves to Lean Long on Q2 GM sustained at or above 25% with capex envelope on guide, and flips to Avoid on Q2 GM below 24% or capex breaching $222M.